Evidence map›Paper›PMID 27137937›Full record

ReviewJournal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology2016

Mitochondrial Quality Control Proteases in Neuronal Welfare.

Roman M Levytskyy, Edward M Germany, Oleh Khalimonchuk

Abstract readReview
In one paragraph

Review in Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Mitoepigenetics and Its Emerging Roles in Cancer.Frontiers in cell and developmental biology · 2020
    Review
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Roman M LevytskyyDepartment of Biochemistry, University of Nebraska-Lincoln, Lincoln, NE, 68588, USA.
Edward M GermanyDepartment of Biochemistry, University of Nebraska-Lincoln, Lincoln, NE, 68588, USA.
Oleh KhalimonchukDepartment of Biochemistry, University of Nebraska-Lincoln, Lincoln, NE, 68588, USA. okhalimonchuk2@unl.edu.

Funding

Redox Biology CenterP30GM103335 · NIGMS · UNIVERSITY OF NEBRASKA LINCOLN · PI BECKER, DONALD F · 2012 to 2016
$4.3M
A Conserved Metalloprotease Required for Mitochondrial Maintenance and ProtectionR01GM108975 · NIGMS · UNIVERSITY OF NEBRASKA LINCOLN · PI KHALIMONCHUK, OLEH · 2014 to 2018
$1.4M
Molecular Mechanisms of DiseaseT32GM107001 · NIGMS · UNIVERSITY OF NEBRASKA LINCOLN · PI BECKER, DONALD F, BLACK, PAUL N. · 2015 to 2019
$1.0M
NIGMS NIH HHS P30 GM103335NIGMS NIH HHS R01 GM108975NIGMS NIH HHS T32 GM107001
6 · The paper itself

Abstract

The functional integrity of mitochondria is a critical determinant of neuronal health and compromised mitochondrial function is a commonly recognized factor that underlies a plethora of neurological and neurodegenerative diseases. Metabolic demands of neural cells require high bioenergetic outputs that are often associated with enhanced production of reactive oxygen species. Unopposed accumulation of these respiratory byproducts over time leads to oxidative damage and imbalanced protein homeostasis within mitochondrial subcompartments, which in turn may result in cellular demise. The post-mitotic nature of neurons and their vulnerability to these stress factors necessitate strict protein homeostatic control to prevent such scenarios. A series of evolutionarily conserved proteases is one of the central elements of mitochondrial quality control. These versatile proteolytic enzymes conduct a multitude of activities to preserve normal mitochondrial function during organelle biogenesis, metabolic remodeling and stress. In this review we discuss neuroprotective aspects of mitochondrial quality control proteases and neuropathological manifestations arising from defective proteolysis within the mitochondrion.

Indexed as

AnimalsHumansMitochondriaNeurodegenerative DiseasesNeuronsOxidative StressPeptide HydrolasesReactive Oxygen SpeciesPeptide HydrolasesReactive Oxygen SpeciesHereditary neurological diseasesMitochondriaMitochondrial proteasesMitochondrial quality controlNeurodegenerative diseasesNeurons

Identifiers

PMID27137937
PMCPMC5093085

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.